We start at the beginning of biotech company creation, with scientists and their scientific hypotheses focused on unearthing breakthroughs in human health. We stay involved from the early science to preclinical development, into the clinic and onto the market.
From the Oxford vaccine to new treatments for diseases with limited therapeutic options, we back innovative platform technologies, novel classes of biologics and small molecule therapeutics, vaccines, and cell and gene therapies.
Katya SmirnyaginaSenior Partner, Life Sciences
The brilliance of the science is a constant reminder of the privileged and important role we play at the heart of Oxford’s dynamic ecosystem. We’re passionate about supporting our academic founders, who are truly at the forefront of their fields and whose research is recognised consistently among the best in the world.